Related Experiment Video
Updated: Aug 8, 2025

09:30
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.5K
Colorimetric Assaying of Exosomal Metabolic Biomarkers
Evelias Yan1,2, Garima Goyal1,2,3, Umit Hakan Yildiz4
1Center for Biomimetic Sensor Science, Nanyang Technological University, Singapore 637553, Singapore.
Molecules (Basel, Switzerland)
|February 25, 2023
Summary
Researchers developed a novel optical detection method for assaying exosomal biomarkers. This rapid assay offers a promising tool for early disease diagnosis by analyzing microRNA, DNA, and advanced glycation end products in exosomes.
Area of Science:
- Biochemistry
- Nanotechnology
- Molecular Biology
Background:
- Exosomes, intraluminal vesicles found in various bodily fluids, contain metabolic biomarkers reflective of cellular origin and physiological state.
- Analysis of exosomal content (DNA, microRNA, proteins, lipids) offers potential for disease biomarker discovery.
- Current methods like ELISA and Nanoparticle Tracking Analysis (NTA) for exosomal biomarker detection are time-consuming and laborious.
Purpose of the Study:
- To develop a novel, rapid, and facile optical detection method for assaying exosomal biomarkers.
- To demonstrate the capability of the proposed method for detecting microRNA, DNA, and advanced glycation end products in human plasma exosomes.
- To provide an alternative to existing time-consuming and labor-intensive biomarker detection assays.
Main Methods:
- Utilized an optical detection method based on changes in the optical properties of poly(3-(4-methyl-3'-thienyloxy) propyltriethylammonium bromide).
- The method involves interaction with aptamers/peptide nucleic acids in the presence or absence of target biomarkers.
- Exosomes were isolated from human plasma for proof-of-concept analysis.
Main Results:
- Demonstrated facile assaying of microRNA, DNA, and advanced glycation end products in exosomes.
- Achieved high sensitivity with detection levels of approximately 1.2 fM/exosome for microRNA, 0.04 fM/exosome for DNA, and 0.35 fM/exosome for advanced glycation end products.
- The optical method showed significant improvements over conventional techniques in terms of speed and ease of use.
Conclusions:
- The proposed optical detection methodology is effective for rapid and facile detection of generic exosomal biomarkers.
- This approach holds significant potential for facilitating early disease diagnosis.
- The study highlights a promising advancement in exosomal biomarker analysis for clinical applications.

